Impurities Standards
Pharmaceutical Impurity, Reference & Working Standards
Pharmaceutical Impurity Standards Developed Through Advanced Analytical Expertise
KNORS Pharma provides high-purity pharmaceutical impurity standards developed through advanced analytical expertise, controlled synthesis, purification and comprehensive molecular characterization.
Our impurity, reference and working standards are designed to support pharmaceutical research, analytical method development, validation, impurity profiling, quality control and regulatory requirements.
- High-purity pharmaceutical impurity standards for analytical validation and impurity profiling.
- Reference standards for APIs and impurities present in finished pharmaceutical dosage forms.
- Standards developed with a strong focus on analytical accuracy, traceability and regulatory alignment.
Pharmaceutical Impurity Standards Developed Through Advanced Analytical Expertise
KNORS Pharma develops pharmaceutical impurity reference standards through scientifically controlled synthesis, isolation, purification and analytical verification processes.
Our scientists work with complex pharmaceutical molecules and impurities to deliver materials suitable for research, analytical testing, method development, validation and quality control applications.
- Custom organic synthesis of pharmaceutical impurities and related compounds.
- Advanced isolation and purification capabilities.
- Comprehensive molecular verification and characterization.
- Regulatory-aligned analytical documentation.
- Scalable custom manufacturing solutions.
- Analytical testing using HPLC, NMR, LC-MS, FT-IR and TGA.
Custom Organic Synthesis Solutions
Our custom organic synthesis capabilities support the development of pharmaceutical impurities, degradation products, process-related impurities, metabolites, intermediates and other analytical reference materials.
- Custom synthesis of pharmaceutical impurities and related compounds.
- Development of difficult-to-source reference and working standards.
- Support for complex molecules and specialized analytical requirements.
Advanced Isolation and Purification
KNORS Pharma uses advanced isolation and purification approaches to obtain high-purity pharmaceutical impurity standards from synthetic reaction mixtures, pharmaceutical products and other relevant sources.
Purification processes are selected according to the chemical and physical characteristics of the target compound to achieve the required purity and analytical suitability.
Comprehensive Molecular Verification
Every pharmaceutical impurity standard requires appropriate characterization and structural confirmation. KNORS Pharma supports molecular verification using complementary analytical techniques to establish the identity, purity and characteristics of the material.
NMR / MS / TGA
KNORS Pharma provides comprehensive characterization of pharmaceutical impurity reference and working standards using advanced analytical techniques.
The characterization package can include Nuclear Magnetic Resonance spectroscopy, mass spectrometry, thermal analysis and other relevant analytical techniques according to the requirements of the compound and application.
In-Depth Structural Confirmation
NMR analysis provides detailed information regarding the molecular structure and supports confirmation of the expected chemical identity of the pharmaceutical impurity or reference standard.
Precise Molecular Mass Validation
Mass spectrometric analysis supports molecular mass confirmation and provides additional evidence for the identity of the target compound.
Thermal Behavior & Moisture Analysis
Thermogravimetric analysis can be used to evaluate thermal behavior, moisture content, solvent loss and other weight changes associated with the material.
Thermal Behavior & Moisture Analysis
Analytical testing supports appropriate potency assignment for pharmaceutical working standards and helps ensure consistency during routine analytical applications.
Regulatory Alignment and Compliance
Our impurity standards are developed with consideration of applicable pharmaceutical quality and regulatory expectations. Documentation and analytical characterization are structured to support research, quality control and regulatory activities.
KNORS Pharma focuses on analytical traceability, appropriate characterization and reliable documentation for pharmaceutical reference and working standards.
Audit-Ready Method Documentation
Appropriate analytical documentation can be provided to support traceability, method understanding, quality review and audit requirements associated with pharmaceutical reference and working standards.
Scalable Custom Manufacturing
Our capabilities support custom requirements ranging from research quantities to larger quantities of pharmaceutical impurity standards, depending on compound complexity, synthesis requirements and customer specifications.
KNORS Pharma works with customers to support specialized requirements for pharmaceutical impurity, reference and working standards.
Analytical Testing and Comprehensive Reports for Pharmaceutical Reference Standards
KNORS Pharma provides analytical testing and characterization support for pharmaceutical impurity and reference standards. Analytical techniques are selected according to the compound, specification and intended application.
Comprehensive analytical reports help customers evaluate the identity, purity, molecular characteristics and other relevant quality attributes of the supplied material.
Drug Impurity Standards Backed by HPLC, NMR, Mass Spectroscopy and TGA Analysis
Our analytical capabilities include a combination of chromatographic, spectroscopic and thermal techniques for comprehensive evaluation of pharmaceutical impurity standards.
- Quantitative HPLC & Purity Profiling: High Performance Liquid Chromatography is used for quantitative purity assessment and impurity profiling. HPLC analysis provides chromatographic information that supports evaluation of the quality and purity of pharmaceutical reference materials.
- Definitive Molecular Proof via NMR: NMR spectroscopy provides structural information that supports confirmation of molecular identity and helps establish the consistency of the supplied pharmaceutical impurity standard with the expected chemical structure.
- Trace Contaminant Mass Profiling: Mass spectrometric analysis supports molecular mass confirmation and can provide additional information regarding related compounds, contaminants and other analytical characteristics.
- Volatiles and Degradation Evaluation: TGA analysis supports the evaluation of weight changes associated with moisture, volatile components, thermal behavior and degradation characteristics of the material.
- Streamlined Method Development Support: Pharmaceutical impurity standards from KNORS Pharma can support analytical method development, method optimization, validation, impurity identification and routine quality control activities.
Documentation
The availability of appropriately characterized reference materials can help analytical laboratories establish and evaluate suitable testing procedures for pharmaceutical products and APIs.
Appropriate analytical documentation supports traceability, method understanding, quality review and audit requirements associated with pharmaceutical reference and working standards.
Who We Serve
KNORS Pharma supports pharmaceutical and biotechnology organizations requiring reliable impurity, reference and working standards for research, development, analytical testing and quality control.
Our services are relevant to organizations involved in pharmaceutical development, manufacturing, analytical testing and regulatory activities.
- Biotechnology companies
- Generic drug manufacturers
- Contract Research Organizations (CROs)
- Pharmaceutical quality testing laboratories
- Analytical development and research laboratories
- Pharmaceutical manufacturers and API developers
Pharmaceutical Impurity, Reference & Working Standards
From custom organic synthesis and advanced purification to molecular characterization and analytical testing, KNORS Pharma provides comprehensive solutions for pharmaceutical impurity and reference standards.
Our combination of scientific expertise, analytical characterization and documentation support enables pharmaceutical organizations to obtain standards suitable for a wide range of research, analytical and quality applications.
Contact KNORS Pharma
For pharmaceutical impurity standards, reference standards, working standards and custom analytical requirements, contact the KNORS Pharma team.
Pharmaceutical Impurity, Reference & Working Standards
Pharmaceutical Impurity Standards
Pharmaceutical Impurity Standards Developed Through Advanced Analytical Expertise
KNORS Pharma provides high-purity pharmaceutical impurity standards developed through advanced analytical expertise, controlled synthesis, purification and comprehensive molecular characterization.
Our impurity, reference and working standards are designed to support pharmaceutical research, analytical method development, validation, impurity profiling, quality control and regulatory requirements.
- High-purity pharmaceutical impurity standards for analytical validation and impurity profiling.
- Reference standards for APIs and impurities present in finished pharmaceutical dosage forms.
- Standards developed with a strong focus on analytical accuracy, traceability and regulatory alignment.
Why Choose KNORS Pharma for Pharmaceutical Impurity Standards?
KNORS Pharma develops pharmaceutical impurity reference standards through scientifically controlled synthesis, isolation, purification and analytical verification processes.
Our scientists work with complex pharmaceutical molecules and impurities to deliver materials suitable for research, analytical testing, method development, validation and quality control applications.
- Custom organic synthesis of pharmaceutical impurities and related compounds.
- Advanced isolation and purification capabilities.
- Comprehensive molecular verification and characterization.
- Regulatory-aligned analytical documentation.
- Scalable custom manufacturing solutions.
- Analytical testing using HPLC, NMR, LC-MS, FT-IR and TGA.
Custom Synthesis
Custom Organic Synthesis Solutions
Our custom organic synthesis capabilities support the development of pharmaceutical impurities, degradation products, process-related impurities, metabolites, intermediates and other analytical reference materials.
- Custom synthesis of pharmaceutical impurities and related compounds.
- Development of difficult-to-source reference and working standards.
- Support for complex molecules and specialized analytical requirements.
Isolation & Purification
Advanced Isolation and Purification
KNORS Pharma uses advanced isolation and purification approaches to obtain high-purity pharmaceutical impurity standards from synthetic reaction mixtures, pharmaceutical products and other relevant sources.
Purification processes are selected according to the chemical and physical characteristics of the target compound to achieve the required purity and analytical suitability.
Comprehensive Molecular Verification
Every pharmaceutical impurity standard requires appropriate characterization and structural confirmation. KNORS Pharma supports molecular verification using complementary analytical techniques to establish the identity, purity and characteristics of the material.
NMR / MS / TGA
KNORS Pharma provides comprehensive characterization of pharmaceutical impurity reference and working standards using advanced analytical techniques.
The characterization package can include Nuclear Magnetic Resonance spectroscopy, mass spectrometry, thermal analysis and other relevant analytical techniques according to the requirements of the compound and application.
In-Depth Structural Confirmation
NMR analysis provides detailed information regarding the molecular structure and supports confirmation of the expected chemical identity of the pharmaceutical impurity or reference standard.
Precise Molecular Mass Validation
Mass spectrometric analysis supports molecular mass confirmation and provides additional evidence for the identity of the target compound.
Thermal Behavior & Moisture Analysis
Thermogravimetric analysis can be used to evaluate thermal behavior, moisture content, solvent loss and other weight changes associated with the material.
Potency Assignment for Working Standards
Analytical testing supports appropriate potency assignment for pharmaceutical working standards and helps ensure consistency during routine analytical applications.
Regulatory Alignment
Regulatory Alignment and Compliance
Our impurity standards are developed with consideration of applicable pharmaceutical quality and regulatory expectations. Documentation and analytical characterization are structured to support research, quality control and regulatory activities.
KNORS Pharma focuses on analytical traceability, appropriate characterization and reliable documentation for pharmaceutical reference and working standards.
Audit-Ready Method Documentation
Appropriate analytical documentation can be provided to support traceability, method understanding, quality review and audit requirements associated with pharmaceutical reference and working standards.
Scalable Custom Manufacturing
Our capabilities support custom requirements ranging from research quantities to larger quantities of pharmaceutical impurity standards, depending on compound complexity, synthesis requirements and customer specifications.
KNORS Pharma works with customers to support specialized requirements for pharmaceutical impurity, reference and working standards.
Analytical Testing
Analytical Testing and Comprehensive Reports for Pharmaceutical Reference Standards
KNORS Pharma provides analytical testing and characterization support for pharmaceutical impurity and reference standards. Analytical techniques are selected according to the compound, specification and intended application.
Comprehensive analytical reports help customers evaluate the identity, purity, molecular characteristics and other relevant quality attributes of the supplied material.
Drug Impurity Standards Backed by HPLC, NMR, Mass Spectroscopy and TGA Analysis
Our analytical capabilities include a combination of chromatographic, spectroscopic and thermal techniques for comprehensive evaluation of pharmaceutical impurity standards.
- Quantitative HPLC & Purity Profiling: High Performance Liquid Chromatography is used for quantitative purity assessment and impurity profiling. HPLC analysis provides chromatographic information that supports evaluation of the quality and purity of pharmaceutical reference materials.
- Definitive Molecular Proof via NMR: NMR spectroscopy provides structural information that supports confirmation of molecular identity and helps establish the consistency of the supplied pharmaceutical impurity standard with the expected chemical structure.
- Trace Contaminant Mass Profiling: Mass spectrometric analysis supports molecular mass confirmation and can provide additional information regarding related compounds, contaminants and other analytical characteristics.
- Volatiles and Degradation Evaluation: TGA analysis supports the evaluation of weight changes associated with moisture, volatile components, thermal behavior and degradation characteristics of the material.
- Streamlined Method Development Support: Pharmaceutical impurity standards from KNORS Pharma can support analytical method development, method optimization, validation, impurity identification and routine quality control activities.
Documentation
The availability of appropriately characterized reference materials can help analytical laboratories establish and evaluate suitable testing procedures for pharmaceutical products and APIs.
Appropriate analytical documentation supports traceability, method understanding, quality review and audit requirements associated with pharmaceutical reference and working standards.
Who We Serve
KNORS Pharma supports pharmaceutical and biotechnology organizations requiring reliable impurity, reference and working standards for research, development, analytical testing and quality control.
Our services are relevant to organizations involved in pharmaceutical development, manufacturing, analytical testing and regulatory activities.
- Biotechnology companies
- Generic drug manufacturers
- Contract Research Organizations (CROs)
- Pharmaceutical quality testing laboratories
- Analytical development and research laboratories
- Pharmaceutical manufacturers and API developers
Pharmaceutical Impurity, Reference & Working Standards
From custom organic synthesis and advanced purification to molecular characterization and analytical testing, KNORS Pharma provides comprehensive solutions for pharmaceutical impurity and reference standards.
Our combination of scientific expertise, analytical characterization and documentation support enables pharmaceutical organizations to obtain standards suitable for a wide range of research, analytical and quality applications.
Connect with Our ExpertsContact KNORS Pharma
For pharmaceutical impurity standards, reference standards, working standards and custom analytical requirements, contact the KNORS Pharma team.
Email: abhishek@knorspharma.com
Phone: +91 1762 406726
Mobile: +91 7409891739